Q4 2025 Tarsons Products Ltd Earnings Call Transcript
Key Points
- Tarsons Products Ltd (BOM:543399) achieved a 7% year-on-year growth in consolidated revenues for Q4 FY25, despite flat to negative trends in the broader industry.
- The company maintained its leadership position in the domestic market and showed resilience during the industry slowdown.
- International revenue grew by 20% year-on-year in FY25, driven by a dual strategy to expand both the Tarsons branded portfolio and OEM/ODM partnerships.
- The company is strategically positioned to capture additional market share with the introduction of new product lines, particularly in cell culture and bioprocess products.
- Tarsons Products Ltd (BOM:543399) acquired Nerbe, a European company, to strengthen its international presence and leverage cross-selling opportunities.
- The plastic labware industry has experienced muted demand over the past six to eight quarters, affecting overall volumes.
- Stand-alone PAT for Q4 FY25 declined due to higher depreciation expenses and increased interest costs from newly acquired debt.
- The company's consolidated EBITDA margin is lower due to Nerbe's trading-focused business model, which carries a lower margin profile.
- The transition from third-party to in-house products at Nerbe will take time, impacting short-term profitability.
- The company faces challenges in scaling up export revenue due to a crowded market with competition from other Asian countries.
Ladies and gentlemen, good day and welcome to the Q4 FY25 earnings conference call of Tarsons Products Limited. (Operator Instructions) Please note that this conference is being recorded.
Kindly note that this conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statement are not the guarantee of the future performance of the company, and it may involve risks and uncertainties that are difficult to predict.
I will now hand the conference over to Mr. Aryan Sehgal, Promoter and Whole Time Director of Tarsons Products Limited. Thank you, and over to you, sir.
Good afternoon, everybody, and a very warm welcome to the Q4 and FY25 earnings conference call of Tarsons Products Limited. Along with me, I'm joined by Santosh, our CFO and Compliance Officer; and SGA, our Investor Relations partners. We have uploaded our earnings presentation on the stock
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
